Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: JD on Stockhouse - Her2-positive brain metastases
Each of Bioasis's pipeline drugs will need its own preclinical and clinical studies. It looks like preclinical work has been or is being done with xB3-001 (trastuzumab), xB3-004 (IL-1Ra), xB3-007 (possibly Gaucher disease with Oxyrane) and xB3-009 (progranulin).
It's possible, even probable, that preclinical work is also being done by Chiesi, Protalix, Prothena and Aposense.
